Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pregabalin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic route for pregabalin intermediates avoids toxic reagents. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN117448309A reveals biocatalytic synthesis for high-purity pregabalin intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN102382785B reveals a novel Morganella morganii strain for high-purity Pregabalin intermediate production, offering significant cost and supply chain advantages.
Patent CN102465157B details enzymatic synthesis of pregabalin intermediate offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel solvent-free route for 4-isobutyl pyrrolidone ensures high purity and cost efficiency for pregabalin supply chains.
Patent CN102382785A details a novel biocatalytic route for high-purity pregabalin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Novel ammonium sulfate process for 3-isobutylglutaric acid. Enhances purity and supply chain reliability for pregabalin intermediate production globally.
Novel green synthesis of ethyl 2-acetyl-3-nitromethylene-5-methyl-hexanoate using recyclable DES solvent, offering high yield and cost efficiency.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Patent CN110803993B reveals a green DES-based synthesis for pregabalin intermediates, offering high yields, recyclable solvents, and scalable mechanochemical processing for cost-effective manufacturing.
Patent CN104086439A offers green recovery for pregabalin intermediates reducing waste and cost for reliable pharmaceutical intermediates supplier partnerships.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN112359036B discloses engineered nitrilase mutants for efficient synthesis of pregabalin chiral intermediates, offering significant cost reduction in API manufacturing.
Novel metal halide catalysis eliminates high-pressure hydrogenation risks. Delivers high-purity lactam compounds with significant cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Advanced manufacturing of (S)-4-isobutyl-dihydro-3H-furan-2-one via a novel Grignard route. Offers significant cost reduction and scalable production for pharmaceutical intermediates.